Skip to content

Inozyme Pharma, Inc.

Delisted

CIK 1693011fmd_1ZZ2T6401H7NRZM0JKFN1DK9R2Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Mar 31, 2025, 25 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading